5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.78▼ | 5.70▲ | 5.74▲ | 5.93▼ | 5.90▼ |
MA10 | 5.75▼ | 5.75▼ | 5.83▼ | 5.90▼ | 5.55▲ |
MA20 | 5.70▲ | 5.85▼ | 5.92▼ | 5.85▼ | 4.80▲ |
MA50 | 5.76▼ | 5.92▼ | 5.83▼ | 5.38▲ | 5.32▲ |
MA100 | 5.85▼ | 5.84▼ | 5.91▼ | 4.47▲ | 7.04▼ |
MA200 | 5.94▼ | 5.89▼ | 5.76▼ | 4.45▲ | 13.86▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.014▲ | -0.018▼ | -0.038▼ | -0.041▼ | 0.212▲ |
RSI | 50.814▲ | 38.989▼ | 41.198▼ | 50.558▲ | 54.920▲ |
STOCH | 81.448▲ | 16.632▼ | 12.513▼ | 53.872 | 61.711 |
WILL %R | -42.857 | -70.423 | -77.895▼ | -69.444 | -40.000 |
CCI | 54.849 | -35.409 | -79.704 | -58.069 | 51.526 |
Wednesday, February 12, 2025 01:00 PM
BOSTON, January 29, 2025--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that ...
|
Wednesday, February 05, 2025 02:32 PM
Dan Paterson, President and CEO of Verastem, Inc. (NASDAQ:VSTM), a clinical-stage biopharmaceutical company with a market capitalization of $273 million, recently sold 858 shares of the company's ...
|
Sunday, February 02, 2025 04:00 PM
Verastem (NASDAQ:VSTM – Free Report) had its price objective hoisted by B. Riley from $7.00 to $9.00 in a research note issued to investors on Friday morning,Benzinga reports.B. Riley currently ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/02/25 | 5.955 | 6.03 | 5.635 | 5.74 | 508,460 |
14/02/25 | 6.14 | 6.17 | 5.87 | 5.97 | 409,300 |
13/02/25 | 6.09 | 6.15 | 5.96 | 6.11 | 361,398 |
12/02/25 | 5.65 | 6.095 | 5.615 | 6.08 | 428,066 |
11/02/25 | 5.53 | 5.76 | 5.41 | 5.74 | 448,300 |
10/02/25 | 5.78 | 5.79 | 5.50 | 5.70 | 758,083 |
07/02/25 | 6.09 | 6.11 | 5.76 | 5.79 | 565,100 |
06/02/25 | 5.93 | 6.1268 | 5.80 | 6.09 | 503,095 |
05/02/25 | 5.90 | 6.16 | 5.77 | 5.95 | 523,700 |
04/02/25 | 5.71 | 5.905 | 5.60 | 5.87 | 649,206 |
|
|
||||
|
|
||||
|
|